Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio Farhat Nasim14 Oct 2019 8:06 AM GMTWhile two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
Fight for Vildagliptin: Natco goes to court against Novartis Farhat Nasim7 Sep 2019 11:02 AM GMTMumbai: Throwing an indirect challenge at patent holder Novartis, drugmaker Natco Pharma has submitted a fresh application in a Hyderabad court...
4 Pharma Giants face price fixing allegations on Vidagliptin: CCI starts probe Ruby Khatun Khatun15 Dec 2017 11:45 AM GMTMumbai: Trouble is mounting for 4 big pharma companies over price fixing of an anti-diabetic drug. An investigation has initiated on drug makers...
Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin savita thakur thakur26 March 2017 6:03 AM GMTThe Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...
